Gregory Levine Quoted on FDA Policy for Direct-to-Consumer Tests
FDA Week and Inside Health Policy quotes life sciences partner Gregory Levine (Washington, D.C.) in a Dec. 18 article that examines the FDA’s policy on direct-to-consumer genetic tests. Mr. Levine explains that the FDA has carved DTC testing out of its enforcement discretion policy.